HPV Vaccination Starting at Age 9
HPV vaccination has the potential to dramatically reduce rates of cervical, oropharyngeal, vaginal, vulvar, anal, and penile cancers. However, HPV vaccination rates in the US lag behind other countries, and HPV vaccine has lower coverage than other adolescent vaccines. Initiation of the vaccine series at ages 9-10 has been suggested as a way to improve vaccination utilization and increase the number of adolescents who complete their series on time. This Collection presents original research on the impact of initiating HPV vaccination at ages 9-10, including population studies and quality improvement projects, as well as commentaries from medical organizations and leading experts in the field.
Edited by
Rebecca Perkins(Boston University Chobanian and Avedisian School of Medicine/ Boston Medical Center)
Kristin Oliver(Departments of Environmental Medicine & Public Health, Pediatrics Icahn School of Medicine at Mount Sinai)
Sharon Humiston(Department of Pediatrics, Division of Urgent Care, Children’s Mercy Kansas City; Professor of Pediatrics, UMKC)